2
Total deals
$70.0M
Total value
$35.0M
Avg deal
$65.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Surface Oncology
Surface Oncology develops next-generation cancer immunotherapy treatments based …
|
2023-06-16 | Merge | Complete | $65.0M | Deal → |
| 2 |
InteKrin
InteKrin Therapeutics is focused on developing and commercializing therapeutics …
|
2014-02-12 | — | Complete | $5.0M | Deal → |